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American ginseng (derived from Panax quinquefolius) is one of the most widely used
medicinal herbs in the world. Because of its high price and increasing demand, there are
many adulterants on the market. The proposed internal transcribed spacer 2 (ITS2) has
been used to identify raw medicinal materials, but it is not suitable for the identification
of Chinese patent medicine ingredients. Therefore, a short barcode for the identification
of processed American ginseng and its corresponding Chinese patent medicines would
be profitable. In this study, 94 samples of American ginseng and Asian ginseng were
collected from all over the world. The ITS2 region was sequenced, and a nucleotide
signature was developed based on one single nucleotide polymorphism (SNP) site
unique to American ginseng. The nucleotide signature (atcactcctt tgcgggagtc gaggcgg)
consists of 27 bases over the length of the ITS2 sequence (420 bp). Furthermore, we
also designed primer pairs to amplify the nucleotide signature; the specific primer pair
4F/4R has been found to be unique to the ginseng species and capable of amplifying
the nucleotide signatures from Chinese patent medicines and decoctions. We used the
nucleotide signature method to inspect ginseng products in Chinese patent medicines;
24 batches of Chinese patent medicine from stores in Beijing were amplified and
sequenced successfully. Using the double peaks at the SNP sites of the nucleotide
signature, 5 batches were found to be counterfeits, and 2 batches were found to
contain adulterants. Thus, this nucleotide signature, with only 27 bp, has broadened the
application of DNA barcoding in identification of decoctions, Chinese patent medicines
and other ginseng products with degraded DNA. This method can rapidly identify ginseng
products and could also be developed as an on-site detection method.
Keywords: American ginseng, Chinese patent medicine, DNA barcoding, internal transcribed spacer, nucleotide
signature
INTRODUCTION
American ginseng (derived from Panax quinquefolius) is one of the most widely used medicinal
herbs in the U.S. (Ang-Lee et al., 2001) and has been used as a traditional Chinese medicine
(TCM) for thousands of years to help attenuate the frequency, severity, and duration of cold
and flu symptoms by reinforcing the immune system (Fuzzati, 2004). American ginseng may
have potential value for colorectal cancer chemoprevention by the conversion of the parent
ginsenosides to bioactive ginseng metabolites (Yu et al., 2015). There are many types of American
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ginseng products, such as root slices, capsules, powders, and
Chinese patent medicines. Over recent years, there has been
a growing demand for ginseng products due to the rapid
emergence of food therapy in herbal medicine. Asian ginseng
and American ginseng are adulterants of each other and
share similar morphological and chemical characteristics, but
they show different pharmacological properties and medicinal
values. It is notoriously difficult to distinguish Asian ginseng
and American ginseng using conventional taxonomic methods,
especially when they have been processed into Chinese patent
medicines or decoctions. One approach is to apply high-
performance liquid chromatography-mass spectrometry (HPLC-
MS), choosing ginsenosides as markers (Chan et al., 2000).
Researchers have extracted at least 30 ginsenosides, including
Rb1, Rb2, Rc, Rd, Re, Rg1, and Rg3, from American ginseng
(Assinewe et al., 2003), but the profiles of the ginsenosides are
similar among the species of this small genus (Chen et al., 2001).
Molecular approaches using DNA as markers with phylogenetic
analysis have received considerable attention in recent years for
the differentiation of closely related species. DNA molecular
markers such as RAPD (Shaw and But, 1995; Mihalov et al.,
2000; Um et al., 2001; In et al., 2005), ISSR (Bang et al., 2004;
In et al., 2005), SSR (Hon et al., 2003; Kim J. et al., 2007), AFLP
(Ha et al., 2002), RFLP (Ngan et al., 1999; Kim O. T. et al.,
2007), SCAR (Wang et al., 2001; Choi et al., 2008), and ARMS
(Park et al., 2006) have been developed for the identification of
American ginseng; however, considering the complex ingredients
and degraded DNA of Chinese patent medicines, these markers
have their own deficiencies. Therefore, a rapid method for
precisely analyzing Chinese patent medicine ginseng products is
highly desirable.
DNA barcoding, a burgeoning molecular technique utilizing
one recognized and relatively short DNA sequence to identify
species (Hollingsworth, 2011; Hollingsworth et al., 2011), is a
relatively simple and universal tool for non-taxonomist scientists
researching plant materials, especially traditional Chinese herbal
medicines. DNA barcodes are convenient, highly efficient, and
accurate, and thus have a wide range of potential applications
in the authentication of medical plants (Hao et al., 2010).
As candidate DNA barcodes in the plant kingdom, ITS/ITS2
sequences have been extensively tested and evaluated (Shilin
et al., 2010). In our previous study, ITS2 exhibited a 91% PCR
recovery efficiency, while ITS only exhibited a 23% recovery
efficiency using one primer pair. Based on 12,861 analyzed
ITS and ITS2 sequences, we concluded that ITS2 can be used
as a mini-barcode to effectively identify species in a wide
variety of specimens and medicinal materials (Han et al., 2013).
Recently, ITS2 has been widely used for herb identification.
Yao et al. (Hui et al., 2010) proposed that ITS2 sequences
can be used as universal markers for the identification of
plant species and established a website with DNA barcodes
for TCMs (http://www.tcmbarcode.cn/) for every researcher’s
convenience. Zhao et al. used ITS2 to identify Acanthopanacis
cortex and its adulterated versions (Zhao et al., 2014). Song
et al. used ITS2 to successfully distinguish commercial Rhodiola
products and found that 60% contained adulterants (Xin
et al., 2015). Chen et al. developed two single nucleotide
polymorphism (SNP) sites in the ITS2 region that can be used
to identify Panax ginseng and Panax quinquefolius (Xiaochen
et al., 2013). This method is suitable for the identification
of medicinal materials, slices, seeds and powders, but it is
unsuitable for the identification of heavily processed materials
such as decoctions and Chinese patent medicines because of
the DNA degradation occurred in the manufacturing processes.
The DNA degradation that occurs in processed biological
material often prevents the recovery of PCR fragments longer
than 200 bp (Goldstein and Rob, 2003; Hajibabaei et al., 2006;
Wandeler et al., 2007). Meusnier et al. proposed the use of
a “mini-barcode” sequence to overcome this obstacle. They
cut the full length CO1 into different lengths; while the 650-
bp length could distinguish 97% of the species tested, the
short lengths of 150 bp and 100 bp achieved 95% and 90%
identification success, respectively (Meusnier et al., 2008). Shaw
et al. (Lo et al., 2015) successfully obtained an 88-bp fragment
from TCM material after it had been boiled for 120min,
but the amplification of a 121-bp fragment was unsuccessful,
indicating that shorter degraded DNA fragment lengths are
more likely to be amplified. The phrase “nucleotide signature”
refers to one or more nucleotides unique to one taxon, and a
nucleotide signature has been used in the identification of Aglaia
stellatopilosa (Ng et al., 2014). These considerations motivated
our group to develop a short nucleotide signature within the
ITS2 region.
This study aimed to develop a short gene identifier for
the differentiation of American ginseng and its Chinese
patent medicines. A 27-bp (atcactcctt tgcgggagtc gaggcgg) gene
identifier was found. This exclusive nucleotide signature of
American ginseng is a section of short motifs that is well
conserved within the species. The developed method was
later used for the analysis of ginseng products, including 24
batches of Chinese patent medicine. Detailed information is
below.
MATERIALS AND METHODS
Collection of Materials
A total of 94 samples of American ginseng and Asian ginseng
were collected by our group from the following locations:
Muling City; Ning’an City, Heilongjiang Province; Ji’an City;
Tonghua City; Jingyu County; Fusong County, Jilin Province;
Xinbin county; Qingyuan county, Liaoning Province; the Beijing
Huairou area; Wendeng City, Shandong Province; the Anguo
herbmarket inHebei Province; the Bozhou herbmarket in Anhui
Province; Canada; and Wisconsin, United States of America.
All the samples were authenticated by Prof. Lin Yulin at the
Institute ofMedicinal Plant Development (IMPLAD). The details
of these samples are listed in Table 1S. We also downloaded
from GenBank all 283 complete ITS2 sequences of the Panax
species that can be confused with P. quinquefolius according
to their morphological characteristics. These sequences were
used as the reference for development of the American ginseng
nucleotide signature. For further study, 24 batches of Chinese
patent medicines containing ginseng products were purchased
from stores in Beijing.
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DNA Extraction, Amplification, and
Sequencing
Root or Powder
Each root sample was sterilized by being scrubbed with
75% ethanol and was then ground by using a ball-milling
machine (Retsch, Germany); 20mg of each ground sample
was subsequently used for the extraction of genomic
DNA. The isolation of DNA was performed with the Plant
Universal Genomic DNA Kit (Tiangen Biotech Beijing
Co., China) according to the manufacturer’s instructions.
The primer pair 2F (ATGCGATACTTGGTGTGAAT)/3R
(GACGCTTCTCCAGACTACAAT) diluted to 2µmol/µL
was used for the amplification of ITS2 (Shu-Jiau et al., 2007).
PCR was performed in a 25-µL reaction system containing
2µL template DNA, 2.5µL PCR Buffer (10×), 2µL Mg2+
(25mmol/L), 2µL dNTP mixture (2.5mmol/L, 1.0µL primers
2F/3R (2.5µmol/L), and 1.0 U Taq DNA polymerase. The
conditions for PCR were 40 cycles at 94◦C for 30 s, 56◦C for
30 s, and 72◦C for 45 s. The PCR process was ended by 10min of
incubation at 72◦C. The purified PCR products were sequenced
by the Major Engineering laboratory of the Chinese Academy of
Agricultural Sciences University with the primer pair 2F/3R. All
the sequences underwent forward and backward sequencing.
Decoction and Chinese Patent Medicine
American ginseng powder (20 g) was boiled in 500mL double-
distilled water for 90min. The volume of the decoction system
was maintained at 500mL throughout the boiling process by
the addition of double-distilled water, and the supernatant of
the resulting decoction was used for DNA extraction. The DNA
from the decoction supernatant was extracted with the Plant
Universal Genomic DNA Kit (Tiangen Biotech Beijing Co.,
China) according to the manufacturer’s instructions. DNA from
the Chinese patent medicine was extracted by cryogenic grinding
and use of the Plant Universal Genomic DNA Kit (Tiangen
Biotech Beijing Co., China). The degraded DNA was amplified
using five primer pairs newly designed using Primer 6.0 software
(Glantz, 2005). Details of these primers are shown in Table 1.
The conditions for PCR were 40 cycles of 94◦C for 30 s, 55◦C
for 30 s, and 72◦C for 45 s. PCR was performed in the same 25-
µL reaction system that was used for the other samples. The
purified PCR products were sequenced by the Major Engineering
laboratory of the Chinese Academy of Agricultural Sciences
University with the newly designed primer pairs.
Sequence Assembly and Alignment
The sequences were assembled using CodonCode Aligner 3.7.1
(CodonCode Co., Germany). We first removed low-quality
motifs at both ends of the sequencing results. Then, all the ITS2
sequences of the Panax genus, including those downloaded from
GenBank, were annotated and delimited using a hidden Markov
Model (HMM)-based method (Keller et al., 2009) to eliminate
the 5.8S and 28S rDNA regions. The haplotypes of every Panax
species were selected by CodonCode Aligner. All the haplotypes
were aligned using MEGA 5 software (Tamura, 2011).
RESULTS
Development of a Nucleotide Signature for
P. quinquefolius
The PCR amplification and sequencing success rates of the
ITS2 region were 100% using the primer pair 2F/3R. The PCR
amplification of all 94 samples produced sequences 420 bp long.
A total of 54 ITS2 sequences of American ginseng generated
from experimental materials and retrieved from GenBank were
aligned. The results showed that the ITS2 regions of all the
individuals within the P. quinquefolius species were completely
conserved. No variable sites were found among them. In
accordance with previous studies (Xiaochen et al., 2013), two
SNPs in ITS2 were found to exist stably between American
ginseng and Asian ginseng. In the two SNPs, the nucleotide
(T) at position 32 was found to be unique to P. quinquefolius.
Based on the SNP site, we developed a 27-bp nucleotide signature
(atcactcctt tgcgggagtc gaggcgg) for American ginseng.
Validate the Nucleotide Signature for
P. quinquefolius
All the haplotypes representing the 283 ITS2 sequences of the
closely related Panax species (downloaded from NCBI) were
TABLE 1 | Primers used for PCR amplification and sequencing.
Primer pair Primer name Direction Primer sequences (5′-3′) Amplicon size Annealing temperature
1 2F Forward ATGCGATACTTGGTGTGAAT 420 56
3R Reverse GACGCTTCTCCAGACTACAAT
2 11F Forward CCCAAATGCGAGTCCTTG 49 55
12R Reverse TTACAACCACCACTTGTCG
3 11F Forward CCCAAATGCGAGTCCTTG 72 55
11R Reverse GCACGACATGAGAAGAGG
4 6F Forward CCCAACCCATCACTCCTT 95 55
4R Reverse GCCAAGGACTCGCATTTG
5 7F Forward CCCAACCCATCACTCCTT 149 55
7R Reverse CGCACGACATGAGAAGAG
6 4F Forward TGCAGAATCCCGTGAACC 168 55
4R Reverse GCCAAGGACTCGCATTTG
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aligned using MEGA 5, and a summary is shown in Figure 1. In
this conserved region of American ginseng, other species have
1–7 divergent nucleotides. Therefore, this region is defined as
the nucleotide signature of P. quinquefolius. The BLAST results
showed that the conserved 27-bp nucleotide region can be used
FIGURE 1 | Result of a nucleotide blast of the 27-nucleotide conserved
region.
to differentiate P. quinquefolius from all the other Panax species
retrieved from the NCBI database. The details of this nucleotide
signature are shown in Figure 2.
Selection of a Species-Specific Primer Pair
for the Amplification the Nucleotide
Signature
We used the American ginseng decoction to verify whether the
nucleotide signature method functions with processed materials.
The complete ITS2 region (420 bp) could not be amplified
from the decoction using universal primer pair 2F/3R. Thus,
we designed five primers for nucleotide signature amplification
by aligning ITS2 sequences and identifying conserved regions
ranging from 50 to 200 bp in size. Visible PCR products were
obtained (Figure 3). The five PCR products were 49 bp, 72 bp,
95 bp, 149 bp, and 168 bp long. The results showed that although
the entire 420-bp ITS2 region could not be amplified, the shorter
barcode can still be amplified from the degraded DNA. Two of
the primer pairs (6F/4R and 7F/7R) were designed at the SNP
sites, thus the nucleotide signature could not be obtained after
sequencing and truncated the primer region. Two other designed
primer pairs (11F/11R and 11F/12R) successfully amplified the
shorter length amplicon, but the PCR product was too short
to be sequenced. The primer 4F/4R successfully amplified the
nucleotide signature, and the sequencing results demonstrated
that the short nucleotide signature was successfully obtained
from the American ginseng decoction.
Validation of the Nucleotide Signature for
the Identification of Chinese Patent
Medicines
The American ginseng in Chinese patent medicines goes through
various processes that make the authentication of commercial
products difficult. Yangshen Baofei Wan is a representative
Chinese patent medicine that contains American ginseng in
addition to 11 other ingredients. The complete ITS2 region
(420 bp) could not be amplified from this Chinese patent
medicine using the universal primer pair 2F/3R. We tested
the ability of the 4F/4R primer pair to amplify the nucleotide
signature region from this Chinese patent medicine. The results
showed that the targeted nucleotide signature of American
ginseng was successfully amplified from the 2 batches of
Yangshen Baofei Wan that were tested (shown in Figure 4). This
positive result led to the following examination of other Chinese
patent medicines containing ginseng products.
To validate this method, 22 batches of other Chinese
patent medicines containing American ginseng, Asia ginseng
and notoginseng were tested. The results showed that the
primer pair 4F/4R was very specific to Panax species. The
PCR and sequencing success rate was 100%. No Asian
ginseng adulterates were found in 1 batch of Xiyangsheng
pills, 2 batches of Xiyangsheng tablets and 2 batches of
Xiyangsheng capsules from different manufacturers. They were
all found be made with genuine American ginseng. Most
Chinese patent medicines contain different types of species.
For example, Dieda pills contain 24 ingredients, including
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FIGURE 2 | Schematic diagram showing the nucleotide signature region of P. quinquefolius.
FIGURE 3 | Six primer pairs amplify the different sizes of sequences
from decoction. Except for the first lane (Marker), each primers pairs takes
up three lanes. Lanes from left to right is 2F/3R, 11F/12R, 11F/11R, 6F/4R,
7F/7R, and 4F/4R. The first lane in each primers pair group (lane 1, 4, 7, 10,
13, and 16) is negative control. The second lane (lane 2, 5, 8, 11, 14, and 17)
is positive control. The third lane (lane 3, 6, 9, 12, 15, and 18) is PCR products
from decoction.
Notoginseng (Sanqi), Angelicae Sinensis Radix (Danggui),
Paeoniae Radix Alba (Baishao), Paeoniae Radix Rubra (Chishao),
Persicae Semen (Taoren), Carthami Flos (Honghua), Draconis
Sanguis (Xuejie), Siphonostegiae Herba (Beiliujinu), Drynariae
Rhizoma (Gusuibu), Dipsaci Radix (Xuduan), Sappan Lignum
(Sumu), Moutan Cortex (Mudanpi), Olibanum (Ruxiang),
Myrrha (Moyao), Curcumae Longae Rhizoma (Jianghuang),
Sparganii Rhizoma (Sanleng), Saposhnikoviae Radix (Fangfeng),
Melo Semen (Tianguazi), Aurantii Fructus Immaturus (Zhishi),
Platycodonis Radix (Jiegeng), Glycyrrhizae Radix et Rhizoma
(Gancao), Akebiae Caulis (Mutong), Pyritum (Zirantong), and
Eupolyphaga Steleophaga (Tubiechong). The primer pair 4F/4R
could specifically amplify the sequence of notoginseng from this
Chinese patent medicine. Direct sequencing of the PCR products
showed very clean traces. Another example is the Qipi pill. Except
for Asian ginseng, there are 10 ingredients in this Chinese patent
medicine, and the 4F/4R primer pair also specifically amplified
the sequence of this Asian ginseng. Thus, the 4F/4R primer pair
exhibited specificity for ginseng products.
By seeking the nucleotide signature developed in this study,
5 of 21 Chinese patent medicines labeled as containing Asian
ginseng were found to contain American ginseng instead.
These were 2 batches of Shenwu Jiannan capsules (HG08MT01,
HG08MT02), 1 batch of Renshen Guipi pills (HG04MT01) and
2 batches of Qipi pills (HG02MT03, HG02MT05) from different
manufacturers. The clean traces showed that there was no Asian
ginseng detected in these five counterfeits. By analyzing the
double peak at the SNP positions (Figure 5), 2 batches were
found to be adulterated with American ginseng (HG02MT06,
HG05MT02). The other 17 Chinese patent medicines that listed
ginseng products as ingredients were found to match their labels.
FIGURE 4 | Six primer pairs amplify the different sizes of sequences
from Yangshen Baofei Pills. Except for the first lane (Marker), each primers
pairs takes up four lanes. Lanes from left to right is 11F/12R, 11F/11R, 6F/4R,
7F/7R, and 4F/4R. The first lane in each primers pair group (lane 1, 5, 9, 13,
and 17) is negative control. The fourth lane (lane 4, 8, 12, 16, and 20) is positive
control. The other two lanes are PCR products from Yanshen Baofei Pills.
DISCUSSION
Why Develop a Nucleotide Signature to
Identify Chinese Patent Medicine
Ingredients
Chinese patent medicines have become commonly prescribed
and can be easily purchased worldwide. However, the
standardization of Chinese patent medicines has still not
been established, and the composition and quality of those
medicines and healthcare products are not guaranteed (Wang
et al., 2011), which can cause disorder in the medicine market.
The supervision of the Chinese patent medicine market is made
even more difficult by the lack of effective standardization
methods.
As a precious herb, American ginseng has often been
processed into different types of products, and heat-processed
American ginseng roots have been reported be more bioactive
than unprocessed roots (Kim K. et al., 2007). Air-dried ginseng
produces weak anti-proliferative effects, whereas steamed
ginseng exhibits a significant increase in anti-proliferative and
pro-apoptotic effects (Sun et al., 2011). However, it is very
difficult to identify these processed materials due to ingredient
DNA degradation. In this case, traditional barcodes such as ITS
and ITS2 are ineffective, and a short reliable marker is required. It
has been reported that the smaller the size of the degraded DNA,
the higher the amplification success rate will be (Särkinen et al.,
2012). This has been demonstrated by a recent study, where a
TCM material was boiled for 120min, and DNA fragments of
88 bp were amplified, but a 121-bp fragment was not (Lo et al.,
2015). Therefore, it is recommended to develop conditions for
producing very short amplicons for the heavily damaged DNA
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FIGURE 5 | Peak profile of four batches of Chinese patent medicine labeled containing Panax species. A-YSBF01 represents Yangsheng baofei Pills.
B-HG04MT02 represents Renshen Guipi Pills. C-HG02MT06 represents Qipi Pills. D-HG05MT02 represents Shenlin Baizhu Capsules. Two SNP sites were framed
respectively in this peak profile. Different bases were represented by peaks of four different colors. Double peaks are clearly examined at SNP sites in Qipi Pills
(C-HG02MT06) and Shenlin Baizhu Capsules (D-HG05MT02).
present in Chinese patent medicines. Therefore, in this study, we
developed a 27-bp nucleotide signature for American ginseng.
A nucleotide signature should be identical in all the
individuals within a given species; i.e., no mutations are allowed
in a nucleotide signature. In this study, a total of 54 ITS2
sequences were used to develop the nucleotide signature of
American ginseng, including 40 samples derived from main
producing areas and 14 samples generated from different
institutes around the world. Furthermore, the results show that
different endemic American ginseng samples share the same
characteristic signature. All the 283 ITS2 sequences of the Panax
genus from GenBank were utilized to verify the nucleotide
signature. Thus, the data was sufficiently broad to be considered
representative. By BLAST analysis, we found that the nucleotide
signature was not present in other Panax species and non-Panax
genera. Thus, the nucleotide signature developed in this study
can be used as a “gene identifier” for American ginseng. Even
the closest related ginseng species has two loci that differ from
the P. quinquefolius signature. Any sample from which the 27-bp
signature sequence (atcactcctt tgcgggagtc gaggcgg) is amplified
can be identified as American ginseng.
The Nucleotide Signature Effectively
Identifies American Ginseng and Ginseng
Products
American ginseng is mainly used to tonify “qi” and nourish
“yin,” and Asian ginseng is known to reinforce “qi” and benefit
the spleen and the lungs. Because American and Asian ginseng
demonstrate different pharmacological properties and medicinal
values, they should be clearly distinguished prior to use in
Chinese patent medicines. As shown in Table 2, out of the 24
batches of Chinese patent medicines tested, 5 that were supposed
to contain Asian ginseng were found to contain American
ginseng. In China, all Chinese patent medicines of the same name
have the same proportions of ingredients and are manufactured
in accordance with the PRC Pharmacopeia’s monograph for
that particular formula. If the detected ingredients are not
consistent with the label, that particular Chinese patent medicine
is considered to be a counterfeit. In this study, the percentage
of counterfeit samples identified out of the 24 commercial
Chinese patent medicine samples was 21%, including 2/2 of
the Shenwu Jiannan capsules, 1/3 of the Renshen Guipi pills,
and 2/7 of the Qipi pills. In a previous study, a mixed powder
of P. ginseng and P. quinquefolius could be clearly identified
by analysis of the double peaks at the SNP positions, and
American ginseng contamination of Asian ginseng as low as
5% could be detected (Xiaochen et al., 2013). In this study,
by seeking the double peaks at the SNP sites, we detected 2
batches of Chinese patent medicine that were adulterated with
American ginseng. The specific primer pair 4F/4R developed
in this study could be used to amplify the nucleotide signature
region and to identify the ginseng product used in Chinese patent
medicines.
American ginseng is known to be more expensive than Asian
ginseng. By investigating the medicinal market, we found that
Frontiers in Plant Science | www.frontiersin.org 6 March 2016 | Volume 7 | Article 319
Liu et al. A Nucleotide Signature of P. quinquefolium
TABLE 2 | List of Chinese patent medicine used in this study.
Voucher number Name of Chinese patent medicine Stores Listed Panax ingredients in label Blast results
YSBF1 Yangsheng baofei pills Stores in Beijing P. quinquefolius P. quinquefolius
YSBF2 Yangsheng baofei pills Stores in Beijing P. quinquefolius P. quinquefolius
HG01MT01 Xiyangsheng pills Stores in Beijing P. quinquefolius P. quinquefolius
HG01MT02 Xiyangsheng tablet Stores in Beijing P. quinquefolius P. quinquefolius
HG01MT09 Xiyangsheng capsules Stores in Beijing P. quinquefolius P. quinquefolius
HG01MT13 Xiyangsheng tablet Stores in Beijing P. quinquefolius P. quinquefolius
HG01MT16 Xiyangsheng capsules Stores in Beijing P. quinquefolius P. quinquefolius
HG02MT01 Qipi pills Stores in Beijing P. ginseng P. ginseng
HG02MT02 Qipi pills Stores in Beijing P. ginseng P. ginseng
HG02MT03 Qipi pills Stores in Beijing P. ginseng P. quinquefolius
HG02MT04 Qipi pills Stores in Beijing P. ginseng P. ginseng
HG02MT05 Qipi pills Stores in Beijing P. ginseng P. quinquefolius
HG02MT06 Qipi pills Stores in Beijing P. ginseng P. ginseng
HG02MT07 Qipi pills Stores in Beijing P. ginseng P. ginseng
HG03MT02 Renshen guipi pills Stores in Beijing P. ginseng P. ginseng
HG04MT01 Renshen guipi pills Stores in Beijing P. ginseng P. quinquefolius
HG04MT02 Renshen guipi pills Stores in Beijing P. ginseng P. ginseng
HG05MT01 Shenlin baizhu capsules Stores in Beijing P. ginseng P. ginseng
HG05MT02 Shenlin baizhu capsules Stores in Beijing P. ginseng P. ginseng
HG07MT01 Shenlin baizhu pills Stores in Beijing P. ginseng P. ginseng
HG07MT04 Shenlin baizhu pills Stores in Beijing P. ginseng P. ginseng
HG08MT01 Shenwu jiannan capsules Stores in Beijing P. ginseng P. quinquefolius
HG08MT02 Shenwu jiannan capsules Stores in Beijing P. ginseng P. quinquefolius
HG09MT02 Dieda pills Stores in Beijing P. notoginseng P. notoginseng
the explanation for why manufacturers adulterate or substitute
Asian ginseng with American ginseng lies in the sales patterns
of the different ginseng products. Normally, Asian ginseng is
sold in the form of a root with its fibrils, while the roots
and fibrils of American ginseng are sold separately, with the
fibrils set at a lower price. The counterfeiters purchase American
ginseng fibrils to substitute for Asian ginseng to produce Chinese
patent medicines. For example, the Qipi pill, a representative
Chinese patent medicine, is mainly examined for Asian ginseng,
according to the PRC Pharmacopeia, by using a microscope
to check whether it contains calcium oxalate cluster crystals.
However, American ginseng and Asian ginseng share similar
microscopic characteristics, therefore consumers are unable to
judge whether the Chinese patent medicine is a counterfeit
or adulterated with American ginseng. Due to the lack of
an identification method, counterfeit drug incidents have been
dramatically increasing over recent years. Every week, new
cases of counterfeit medicine are reported around the world
(Dégardin et al., 2014). In this study, we collected 7 batches
of Qipi pills from different manufacturers. 2 of them were
identified as counterfeitsand and 1 of them was discovered to
be adulterated with American ginseng using this nucleotide
signature method. This method has been demonstrated to be
effective for the detection of ginseng products in Chinese patent
medicines.
The 27-bp Nucleotide Signature
Dramatically Broadens the Applications of
DNA Barcoding for Market Supervision
One important application of the nucleotide signature lies in
obtaining sequence information from Chinese patent medicines
and degraded biological materials. Due to the degree of
processing of these materials, it is very difficult to amplify
relatively long sequences. Indeed, many ginseng products
appearing in the market have been boiled, which undoubtedly
leads to the degradation of DNA. In the manufacturing of
Chinese patent medicines, there are many types of TCM
materials that undergo different processing techniques. Thus,
the method developed in this study had widely application in
authenticate ginseng products contained in these medicines.
For the first time, the nucleotide signature (atcactcctt
tgcgggagtc gaggcgg) is proposed for the identification of
American ginseng. The nucleotide signature, a type of molecular
marker that is more specific than a DNA barcode, is a very
efficient tool for the identification of American ginseng and
ginseng products. The nucleotide signature can be detected
without regard to the sample type or cultivation site. Our group
has developed several nucleotide signatures for different types
of TCMs, such as Notoginseng (Sanqi) and Angelicae Sinensis
Radix (Danggui). The nucleotide signature can be successfully
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amplified from natural plants, root slices, powder products,
decoctions and Chinese patent medicines.
Because the price of American ginseng is very high, there
are also other adulterants, including Angelicae Dahuricae Radix
(Baizhi), Adenophorae Radix (Nanshashen), and Platycodonis
Radix (Jiegeng), which exist in the domestic and international
markets. These adulterants belong to different families, and the
sequence divergences for this nucleotide signature region are
very large, which further confirms the specificity of this signature
for American ginseng. The nucleotide signature is sufficient and
necessary for the identification of American ginseng in Chinese
patent medicines. The developed method is rapid, accurate,
reliable and highly sensitive for the identification of ginseng
products. Therefore, the nucleotide signature, with only 27 bp,
has demonstrated promise for the application of the detection of
ginseng products in Chinese patent medicines.
However, to distinguish all the ingredients in complex
Chinese patent medicines, we recommend the high-throughput
sequencing method, which uses an emulsion PCR approach
to simultaneously amplify several thousand 100–200-bp DNA
molecules in one reaction and yields a large number of short
sequences at a lower cost than standard approaches. For
the further study of Chinese patent medicine ingredients, a
promising direction would be to combine the short nucleotide
signature method with the high-throughput sequencing method.
CONCLUSION
In this study, we found a 27-bp nucleotide signature within the
ITS2 region that can be uniquely detected in American ginseng
and its products. Except for American ginseng, none of the
other species displayed this nucleotide signature. The nucleotide
signature method dramatically broadens the applications of
DNA barcoding in Chinese patent medicine. The 4F/4R primer
developed in this study could specifically amplify the nucleotide
signature region from Chinese patent medicines and decoctions.
Further studies on the application of nucleotide signatures
to other valuable and precious species would undoubtedly be
promising and beneficial.
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